TERT and cancer: Moreover, our analysis of cancer cells reveals that Telo-seq can efficiently distinguish between TERT+ and ALT+ cancer cells (Fig. 5b–d), establishing Telo-seq as a reliable method of TMM prediction, an essential prerequisite to target TMM-specific vulnerabilities in a personalized cancer therapy22.